Y-Intercept (HK)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Y-Intercept (HK)'s DGX Position: Q3 2026 in Review
Y-Intercept (HK) opened a new position in Quest Diagnostics (DGX) in Q3 2026: 11,799 shares worth $2.75M. The stake represents 0.06% of the portfolio and ranks #469 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in DGX as recently as Q1 2026.
Y-Intercept (HK) first reported a position in DGX in Q1 2021 and has held it in 11 quarters since. The position peaked at $5.19M in Q4 2025. 703 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Y-Intercept (HK) held 11,799 shares of Quest Diagnostics worth $2.75M as of Q3 2026.
- Quest Diagnostics was a new Y-Intercept (HK) position in Q3 2026.
- Quest Diagnostics made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #469 holding.
- Y-Intercept (HK) first reported a position in Quest Diagnostics in Q1 2021 and has held it in 11 quarters since.
- Y-Intercept (HK)'s Quest Diagnostics position peaked at $5.19M in Q4 2025.
- 703 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.